on tirzepatide and not losing weight The Science Behind Medical Loss: How It Works to Help You Lose Weight Safely How Tirzepatide Helps You Lose

You may need to lessen your dosage for your next dose in order to minimize risk and/or severity of potential side effects

Additionally, it is not suitable for individuals with pancreatitis, diabetic retinopathy, kidney issues, gallbladder disease, severe gastroparesis, or type 1 diabetes

Patients who took tirzepatide in that 2022 trial lost up to 22.5% of their body weight

For instance, tirzepatide, a dual-target agonist of GLP-1R/GIPR, has shown superior glucose-lowering effects than semaglutide in phase III clinical trial 8

It's important to note that Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are FDA-approved for chronic weight management, while Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for type 2 diabetes management, though sometimes used off-label for weight loss